After a placebo run-in period, patients were assigned to mexazolam 1mg three times daily (n = 32) or placebo (n = 28) for 21 days. Effects on psychomotor performance were evaluated with the Leeds ...

placebo-controlled randomised study with a 4-week placebo run-in period was performed. Euglycaemic hyperinsulinaemic clamp tests and 24-hour ambulatory blood pressure measurements were performed ...

The study is expected to randomize approximately 1,800 patients in two arms equally to receive omecamtiv mecarbil or placebo. Eligible patients will enter a two-week run-in period, following which ...

After a 2-week washout period and a 2-week, single-blind, placebo run-in period, each patient was randomly assigned to 8 weeks of treatment in one of eight groups: 100 mg, 200 mg, or 400 mg ...